Lansoprazole



Lansoprazole





(lanz ah’ pray zol)

PrevacidDNC, Prevacid 24 Hr

PREGNANCY CATEGORY B


Drug Classes

Antisecretory drug

Proton pump inhibitor


Therapeutic Actions

Gastric acid-pump inhibitor: Suppresses gastric acid secretion by specific inhibition of the hydrogen–potassium ATPase enzyme system at the secretory surface of the gastric parietal cells; blocks the final step of acid production.


Indications



  • Short-term treatment (up to 4 wk) of active duodenal ulcer


  • Short-term treatment (up to 8 wk) of gastric ulcers


  • Healing of NSAID-related gastric ulcer


  • Risk reduction for NSAID-related gastric ulcer


  • Short-term treatment (up to 8 wk) of GERD: Severe erosive esophagitis; poorly responsive symptomatic GERD


  • Long-term treatment of pathologic hypersecretory conditions (eg, Zollinger-Ellison syndrome, multiple adenomas, systemic mastocytosis)


  • Maintenance therapy for healing of erosive esophagitis, duodenal ulcers


  • Eradication of Helicobacter pylori infection in patients with active or recurrent duodenal ulcers in combination with clarithromycin and amoxicillin


  • Treatment of frequent heartburn (Prevacid 24 Hr)


  • Unlabeled uses: Alternate-day dosing for management of reflux esophagitis, laryngitis



Available Forms

DR capsulesDNC—15, 30 mg; orally disintegrating DR tablets—15, 30 mg


Dosages

Adults

Jul 21, 2016 | Posted by in NURSING | Comments Off on Lansoprazole

Full access? Get Clinical Tree

Get Clinical Tree app for offline access